VistaGen Therapeutics Inc. (VTGN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    VistaGen Therapeutics Inc...

    NASDAQ: VTGN · Real-Time Price · USD
    3.53
    0.16 (4.75%)
    At close: Sep 26, 2025, 3:59 PM
    3.53
    0.00%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    VistaGen Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 67.13M 119.17M 16.64M 68.14M 103.11M
    Short-Term Investments
    		 13.35M n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 454K 726K 814.2K 569.1K 576.8K
    Receivables
    		 n/a n/a 274.7K 337.9K 40.6K
    Inventory
    		 n/a n/a -735.6K n/a 942.2K
    Other Current Assets
    		 1.59M 74K 528.7K 2.33M -95.4K
    Total Current Assets
    		 82.08M 120.67M 17.51M 71M 104.12M
    Property-Plant & Equipment
    		 1.81M 2.25M 2.77M 3.08M 3.59M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.27M 2.98M 3.58M 3.65M 4.16M
    Total Assets
    		 84.34M 123.65M 21.09M 74.64M 108.28M
    Account Payables
    		 653K 1.55M 2.47M 2.76M 838.3K
    Deferred Revenue
    		 2.59M 791K 714.3K 1.24M 1.42M
    Short-Term Debt
    		 n/a 550K 105K 433.3K 367.8K
    Other Current Liabilities
    		 3.36M 1.07M -6.9K 829.7K -367.8K
    Total Current Liabilities
    		 12.61M 5.12M 4.57M 5.77M 4.19M
    Long-Term Debt
    		 n/a n/a 2.13B n/a n/a
    Other Long-Term Liabilities
    		 391K 2.67M -2.13B 1.56M 6.27M
    Total Long-Term Liabilities
    		 1.34M 4.24M 4.44M 4.16M 12.11M
    Total Liabilities
    		 13.95M 9.37M 9.01M 9.93M 16.3M
    Total Debt
    		 1.51M 2.12M 2.72M 3.04M 3.72M
    Book Value
    		 70.39M 114.29M 12.08M 64.72M 91.98M
    Book Value Per Share
    		 2.29 5.90 1.74 9.81 32.04
    Common Stock
    		 29K 27K 7.3K 206.7K 180.8K
    Retained Earnings
    		 -407.63M -356.21M -326.85M -267.6M -219.84M
    Comprehensive Income
    		 5K n/a n/a n/a n/a
    Shareholders Equity
    		 70.39M 114.29M 12.08M 64.72M 91.98M
    Total Investments
    		 13.35M n/a n/a n/a n/a

    Add to Watchlist